Matches in Wikidata for { <http://www.wikidata.org/entity/Q37440333> ?p ?o ?g. }
Showing items 1 to 74 of
74
with 100 items per page.
- Q37440333 description "article científic" @default.
- Q37440333 description "article scientifique" @default.
- Q37440333 description "articolo scientifico" @default.
- Q37440333 description "artigo científico" @default.
- Q37440333 description "artículu científicu espublizáu en 2009" @default.
- Q37440333 description "bilimsel makale" @default.
- Q37440333 description "scientific article published on 09 April 2009" @default.
- Q37440333 description "vedecký článok" @default.
- Q37440333 description "vetenskaplig artikel" @default.
- Q37440333 description "videnskabelig artikel" @default.
- Q37440333 description "vědecký článek" @default.
- Q37440333 description "wetenschappelijk artikel" @default.
- Q37440333 description "wissenschaftlicher Artikel" @default.
- Q37440333 description "наукова стаття, опублікована у квітні 2009" @default.
- Q37440333 description "научни чланак" @default.
- Q37440333 description "مقالة علمية نشرت في 09 أبريل 2009" @default.
- Q37440333 name "Effects of the end point adjudication process on the results of the Perindopril Protection Against Recurrent Stroke Study (PROGRESS)." @default.
- Q37440333 name "Effects of the end point adjudication process on the results of the Perindopril Protection Against Recurrent Stroke Study (PROGRESS)." @default.
- Q37440333 name "Effects of the end point adjudication process on the results of the Perindopril Protection Against Recurrent Stroke Study" @default.
- Q37440333 type Item @default.
- Q37440333 label "Effects of the end point adjudication process on the results of the Perindopril Protection Against Recurrent Stroke Study (PROGRESS)." @default.
- Q37440333 label "Effects of the end point adjudication process on the results of the Perindopril Protection Against Recurrent Stroke Study (PROGRESS)." @default.
- Q37440333 label "Effects of the end point adjudication process on the results of the Perindopril Protection Against Recurrent Stroke Study" @default.
- Q37440333 prefLabel "Effects of the end point adjudication process on the results of the Perindopril Protection Against Recurrent Stroke Study (PROGRESS)." @default.
- Q37440333 prefLabel "Effects of the end point adjudication process on the results of the Perindopril Protection Against Recurrent Stroke Study (PROGRESS)." @default.
- Q37440333 prefLabel "Effects of the end point adjudication process on the results of the Perindopril Protection Against Recurrent Stroke Study" @default.
- Q37440333 P1433 Q37440333-30513227-F66A-4C47-9656-C0FDD49C2031 @default.
- Q37440333 P1476 Q37440333-81CDBBDD-11A7-4543-9147-A16CD54812A1 @default.
- Q37440333 P2093 Q37440333-3D14F8FE-0FAD-45F8-AC84-BF55971611F7 @default.
- Q37440333 P2093 Q37440333-53D8E4A5-6A08-4BCD-99F6-9589F174588E @default.
- Q37440333 P2093 Q37440333-5E30609E-5704-46B6-AF63-B7B3A2D26C02 @default.
- Q37440333 P2093 Q37440333-9262A97B-7210-4977-BABB-BDF7D2865B56 @default.
- Q37440333 P2093 Q37440333-B5052C94-817F-4880-8F1B-37F14FEAAEBC @default.
- Q37440333 P2093 Q37440333-C3453FBC-83DA-4DD7-89F8-BE1602EF56AC @default.
- Q37440333 P2093 Q37440333-CDEFEC43-152D-4EFA-A3C2-893B10646A17 @default.
- Q37440333 P2093 Q37440333-E1D75B5F-A5A9-4D1D-A6BD-67121074CB1C @default.
- Q37440333 P2093 Q37440333-E438EA8D-5D79-4533-B6CB-E327F27B4AAF @default.
- Q37440333 P2093 Q37440333-F51BFA46-867E-4B99-941A-5C3D3C81E9C6 @default.
- Q37440333 P304 Q37440333-517C1C33-053A-4218-A17B-3E4C9B5100A0 @default.
- Q37440333 P31 Q37440333-E91522AA-01F3-4F5D-B392-D0FF5E13ADAB @default.
- Q37440333 P356 Q37440333-BF3BDA43-3408-4584-AD7A-EC3CB45F90D1 @default.
- Q37440333 P407 Q37440333-5ED9880A-216A-488F-BE0C-3DDAA9DE332F @default.
- Q37440333 P433 Q37440333-227AD9D4-F8FF-47BE-AD8E-888133329DEA @default.
- Q37440333 P478 Q37440333-B7EAEB87-5A17-4764-AA6B-FE99157969F4 @default.
- Q37440333 P50 Q37440333-E3141561-C58F-4787-9B04-A75CD1BED50E @default.
- Q37440333 P577 Q37440333-497FA9D5-B2A2-4466-83FE-8CE9084FED40 @default.
- Q37440333 P5875 Q37440333-A09EEFC4-A276-4B73-B696-89F5A7FAADE8 @default.
- Q37440333 P698 Q37440333-1B1158F7-B018-4412-ACB3-F3C606C87021 @default.
- Q37440333 P921 Q37440333-29068199-85B3-47C4-B221-EA34E5AB0664 @default.
- Q37440333 P356 STROKEAHA.108.539601 @default.
- Q37440333 P698 19359647 @default.
- Q37440333 P1433 Q7624282 @default.
- Q37440333 P1476 "Effects of the end point adjudication process on the results of the Perindopril Protection Against Recurrent Stroke Study (PROGRESS)." @default.
- Q37440333 P2093 "Brian Chambers" @default.
- Q37440333 P2093 "Bruce Neal" @default.
- Q37440333 P2093 "Chris Bladin" @default.
- Q37440333 P2093 "Gary Gordon" @default.
- Q37440333 P2093 "Geoff Donnan" @default.
- Q37440333 P2093 "John Chalmers" @default.
- Q37440333 P2093 "Mark Woodward" @default.
- Q37440333 P2093 "Neil Anderson" @default.
- Q37440333 P2093 "Norman Sharpe" @default.
- Q37440333 P2093 "PROGRESS Collaborative Group" @default.
- Q37440333 P304 "2111-2115" @default.
- Q37440333 P31 Q13442814 @default.
- Q37440333 P356 "10.1161/STROKEAHA.108.539601" @default.
- Q37440333 P407 Q1860 @default.
- Q37440333 P433 "6" @default.
- Q37440333 P478 "40" @default.
- Q37440333 P50 Q89590337 @default.
- Q37440333 P577 "2009-04-09T00:00:00Z" @default.
- Q37440333 P5875 "24271228" @default.
- Q37440333 P698 "19359647" @default.
- Q37440333 P921 Q277785 @default.